AN ENHANCED SENSOR FOR A CONTINUOUS BIOLOGICAL MONITOR

(19)

(11)

EP 3 773 205 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	05.04.2023 Bulletin 2023/14

(45)	Mention of the grant of the patent:
	01.03.2023 Bulletin 2023/09

(21)	Application number: 19782061.6

(22)	Date of filing: 05.04.2019

(51)

International Patent Classification (IPC):

A61B 5/145^(2006.01)
A61B 5/00^(2006.01)
C25D 9/02^(2006.01)

A61B 5/1486^(2006.01)
C12N 9/04^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	C12N 9/0006; C12Y 101/01027; C12Y 101/0103; C12Y 101/03004; C25D 9/02; A61B 5/14865; A61B 5/14532; Y02E 60/50; Y02E 60/10

(86)	International application number:
	PCT/US2019/026028

(87)	International publication number:
	WO 2019/195704 (10.10.2019 Gazette 2019/41)

(54)	AN ENHANCED SENSOR FOR A CONTINUOUS BIOLOGICAL MONITOR VERBESSERTER SENSOR FÜR EINEN KONTINUIERLICHEN BIOLOGISCHEN MONITOR CAPTEUR AMÉLIORÉ POUR UN MONITEUR BIOLOGIQUE CONTINU

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

06.04.2018 US 201862653821 P
25.01.2019 US 201962796832 P
25.01.2019 US 201962796842 P

(43)	Date of publication of application:
	17.02.2021 Bulletin 2021/07

(60)	Divisional application:
	23158880.7

(73)	Proprietor: Zense-Life Inc.
	Carlsbad, California 92010 (US)

(72)	Inventors:
	BOOCK, Robert James Carlsbad, California 92010 (US) ZHANG, Huashi Carlsbad, California 92010 (US)

(74)	Representative: Haseltine Lake Kempner LLP
	One Portwall Square Portwall Lane Bristol BS1 6BH Bristol BS1 6BH (GB)

(56)

References cited: :

WO-A1-2016/049243
US-A1- 2003 217 966
US-A1- 2011 144 465
US-A1- 2018 094 290
US-B2- 8 906 210

US-A1- 2003 129 314
US-A1- 2009 247 856
US-A1- 2014 367 246
US-B2- 8 414 750

C. SABY ET AL: "Glucose sensor based on carbon paste electrode incorporating poly(ethylene glycol) -modified glucose oxidase and various mediators", ANALYTICA CHIMICA ACTA, vol. 304, no. 1, 1 March 1995 (1995-03-01) , pages 33-39, XP055646277, AMSTERDAM, NL ISSN: 0003-2670, DOI: 10.1016/0003-2670(94)00545-W

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).